Literature DB >> 12103254

Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.

Nicolas Lamblin1, Christophe Bauters, Xavier Hermant, Jean-Marc Lablanche, Nicole Helbecque, Philippe Amouyel.   

Abstract

OBJECTIVES: Our hypothesis was that functional polymorphisms in matrix metalloproteinase (MMP) genes may act as susceptibility factors for the development of coronary aneurysms (CAs).
BACKGROUND: Different forms of remodeling have been described at the level of coronary arteries; CA, reported in 1% to 5% of patients with angiographic evidence of coronary artery disease (CAD), are one of them. Matrix metalloproteinases have been implicated in the pathogenesis of aneurysm development through increased proteolysis of extracellular matrix proteins.
METHODS: We screened 3,862 patients who underwent coronary angiography and identified 113 patients with CAD with at least one CA (CA group); these patients were matched with 226 patients with CAD without CA (control group). The -1,306 C/T MMP-2, 5A/6A MMP-3, CA-repeat MMP-9 and -82 A/G MMP-12 polymorphisms were determined.
RESULTS: The MMP-2, MMP-9 and MMP-12 polymorphisms were not associated with CA. By contrast, the 5A/5A genotype of MMP-3 was significantly more frequent in the CA group than in the control group (31% vs. 18%, p = 0.015); similarly, the MMP-3 5A allele was more frequent in the CA group (p = 0.009). Three variables were independently associated with CA: the MMP-3 5A/5A genotype (odds ratio [OR] = 2.23, 95% confidence interval [CI] [1.27 to 3.93]), a previous myocardial infarction (OR = 1.91, 95% CI [1.14 to 3.20]) and a history of aortic aneurysm (OR = 21.06, 95% CI [2.35 to 188]).
CONCLUSIONS: The MMP-3 5A allele is associated with the occurrence of CA. Our results suggest that an increased proteolysis in the arterial wall may act as a susceptibility factor for the development of CA in patients with coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12103254     DOI: 10.1016/s0735-1097(02)01909-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  54 in total

1.  Transgenic expression of matrix metalloproteinase-2 induces coronary artery ectasia.

Authors:  Sia Dahi; Joel S Karliner; Rajabrata Sarkar; David H Lovett
Journal:  Int J Exp Pathol       Date:  2010-10-29       Impact factor: 1.925

2.  Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk.

Authors:  Yun Zhai; Wei Qiu; Xiao-Jia Dong; Xiu-Mei Zhang; Wei-Min Xie; Hong-Xing Zhang; Xiao-Yan Yuan; Gang-Qiao Zhou; Fu-Chu He
Journal:  Gut       Date:  2007-03       Impact factor: 23.059

3.  Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.

Authors:  Benjamin D Horne; Nicola J Camp; John F Carlquist; Joseph B Muhlestein; Matthew J Kolek; Zachary P Nicholas; Jeffrey L Anderson
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

4.  Multiple giant coronary artery aneurysms.

Authors:  Rammohan Marla; Rachel Ebel; Marcus Crosby; G Hossein Almassi
Journal:  Tex Heart Inst J       Date:  2009

5.  Coexistence and management of abdominal aortic aneurysm and coronary artery disease.

Authors:  Mateusz K Hołda; Paweł Iwaszczuk; Karolina Wszołek; Jakub Chmiel; Andrzej Brzychczy; Mariusz Trystuła; Marcin Misztal
Journal:  Cardiol J       Date:  2018-09-20       Impact factor: 2.737

6.  Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.

Authors:  Young Mi Hong; Hyun-Seung Jin; In Sook Park; Soo-Jong Hong
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

7.  Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.

Authors:  Robert C Kaplan; Nicholas L Smith; Stanley Zucker; Susan R Heckbert; Kenneth Rice; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2008-03-14       Impact factor: 5.162

8.  Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaB.

Authors:  Veronika Souslova; Paul A Townsend; Jelena Mann; Chris M van der Loos; Anna Motterle; Fulvio D'Acquisto; Derek A Mann; Shu Ye
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

Review 9.  Novel insights into an old controversy: is coronary artery ectasia a variant of coronary atherosclerosis?

Authors:  Ertan Yetkin; Johannes Waltenberger
Journal:  Clin Res Cardiol       Date:  2007-04-26       Impact factor: 5.460

10.  Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.

Authors:  Jeong-Ah Park; Kyung-Sue Shin; Youn Woo Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.